<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Questions about thrombolytic management arise frequently, often with the intent of ascertaining safety and efficacy in specific situations </plain></SENT>
<SENT sid="1" pm="."><plain>Thrombolytic therapy is generally safe, even if a nonruptured <z:hpo ids='HP_0004944'>intracranial aneurysm</z:hpo> is present </plain></SENT>
<SENT sid="2" pm="."><plain>The risk of <z:e sem="disease" ids="C0018813" disease_type="Disease or Syndrome" abbrv="">cardiac rupture</z:e> with tamponade is low, except for the first 7Â weeks following <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Over this duration, there is an increased risk of intravenous thrombolytic therapy in specific patient groups </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> infrequently occurs during cardiac catheterization </plain></SENT>
<SENT sid="5" pm="."><plain>Its infrequent occurrence has limited large treatment trials </plain></SENT>
<SENT sid="6" pm="."><plain>Basilar <z:mp ids='MP_0006134'>artery occlusion</z:mp> management will be reviewed </plain></SENT>
<SENT sid="7" pm="."><plain>Thrombolytic therapy is generally safe in the context of pre-existing cerebral microhemorrhages and cervical <z:e sem="disease" ids="C0002949" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">artery dissections</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Additionally, the role of multimodal penumbral imaging in planning <z:hpo ids='HP_0001297'>stroke</z:hpo> therapy will be reviewed </plain></SENT>
</text></document>